Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phreesia (PHR) Research & Development (2018 - 2026)

Phreesia (PHR) has disclosed Research & Development for 9 consecutive years, with $30.9 million as the latest value for Q1 2026.

  • Quarterly Research & Development rose 4.38% to $30.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $121.5 million through Jan 2026, up 3.51% year-over-year, with the annual reading at $121.5 million for FY2026, 3.51% up from the prior year.
  • Research & Development hit $30.9 million in Q1 2026 for Phreesia, up from $29.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $31.8 million in Q2 2025 to a low of $17.5 million in Q1 2022.
  • Historically, Research & Development has averaged $27.1 million across 5 years, with a median of $28.9 million in 2024.
  • Biggest five-year swings in Research & Development: surged 175.3% in 2022 and later fell 0.91% in 2025.
  • Year by year, Research & Development stood at $22.7 million in 2022, then rose by 25.92% to $28.5 million in 2023, then grew by 2.7% to $29.3 million in 2024, then grew by 0.47% to $29.5 million in 2025, then grew by 5.0% to $30.9 million in 2026.
  • Business Quant data shows Research & Development for PHR at $30.9 million in Q1 2026, $29.5 million in Q4 2025, and $29.3 million in Q3 2025.